Recurrent Thyroid Gland Carcinoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08875 | Cabozantinib | 1 | Active Not Recruiting | 1 |
| DB08912 | Dabrafenib | 1 | Active Not Recruiting | 1 |
| DB01259 | Lapatinib | 1 | Active Not Recruiting | 1 |
| DB06176 | Romidepsin | 1 | Recruiting | 1 |
| DB04849 | Cediranib | 1 / 2 | Active Not Recruiting | 1 |
| DB00480 | Lenalidomide | 1 / 2 | Active Not Recruiting | 1 |
| DB08916 | Afatinib | 2 | Recruiting | 1 |
| DB08885 | Aflibercept | 2 | Completed | 1 |
| DB08875 | Cabozantinib | 2 | Active Not Recruiting | 1 |
| DB08865 | Crizotinib | 2 | Recruiting | 1 |
| DB08912 | Dabrafenib | 2 | Recruiting | 1 |
| DB01254 | Dasatinib | 2 | Recruiting | 1 |
| DB09078 | Lenvatinib | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB09330 | Osimertinib | 2 | Recruiting | 1 |
| DB09073 | Palbociclib | 2 | Recruiting | 1 |
| DB06589 | Pazopanib | 2 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB06366 | Pertuzumab | 2 | Recruiting | 1 |
| DB11689 | Selumetinib | 2 | Completed | 1 |
| DB11689 | Selumetinib | 2 | Recruiting | 1 |
| DB00398 | Sorafenib | 2 | Active Not Recruiting | 1 |
| DB01268 | Sunitinib | 2 | Active Not Recruiting | 1 |
| DB01268 | Sunitinib | 2 | Recruiting | 1 |
| DB12108 | Taselisib | 2 | Recruiting | 1 |
| DB08911 | Trametinib | 2 | Recruiting | 2 |
| DB00072 | Trastuzumab | 2 | Recruiting | 1 |
| DB05773 | Trastuzumab emtansine | 2 | Recruiting | 1 |
| DB08828 | Vismodegib | 2 | Recruiting | 1 |